NR3C2 and metabolic dysfunction-associated steatotic liver disease: Finally, emerging data suggest that the mineralocorticoid receptor (MR) may influence the risk and progression of MASLD not only through direct hepatic mechanisms but also via its role in regulating immune responses along the spleen–liver axis.